Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
100.0%

Trials by Status

completed125%
recruiting375%

Recent Activity

3 active trials
Showing 4 of 4
recruiting

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

NCT04541654
recruiting

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

NCT05265429
recruiting

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

NCT05587439
completed

Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia

NCT03636867

Clinical Trials (4)

Showing 4 of 4 trials
NCT04541654

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Recruiting
NCT05265429

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Recruiting
NCT05587439

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

Recruiting
NCT03636867

Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia

Completed

All 4 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
4